{"entity":{"type":"insider","cik":"0001845872","url":"/insider/0001845872","json_url":"/insider/0001845872.json","name":"Angermayer Christian","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":19,"first":"2021-06-24","last":"2026-08-20","span_basis":"filed_date"},"name_variants":[{"name":"Angermayer Christian","source":"filing","n_filings":19,"first_seen":"2021-06-24","last_seen":"2026-08-20"}],"transactions":[{"id":9299704,"accession":"0001193125-26-357979","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-357979","line_url":"/filing/0001193125-26-357979","is_derivative":false,"issuer_cik":"0001956439","issuer_name":"Enhanced Group Inc.","issuer_ticker":"ENHA","issuer_name_source":null,"issuer_url":"/issuer/0001956439","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.; Enhanced Holdings LP","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1674316.0,"shares_display":"1,674,316","price_per_share":1.659451417772989,"price_display":"1.66","price_state":"stated","total_value":2778446.06,"total_display":"2,778,446.06","total_whole":"2,778,446","shares_owned_after":36950951.0,"shares_owned_after_display":"36,950,951","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"insider","n_lines":2},{"id":9299702,"accession":"0001193125-26-357979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-357979","line_url":"/filing/0001193125-26-357979#line-1","is_derivative":false,"issuer_cik":"0001956439","issuer_name":"Enhanced Group Inc.","issuer_ticker":"ENHA","issuer_name_source":null,"issuer_url":"/issuer/0001956439","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.; Enhanced Holdings LP","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":93000.0,"shares_display":"93,000","price_per_share":1.7012,"price_display":"1.70","price_state":"stated","total_value":158211.6,"total_display":"158,211.60","total_whole":"158,212","shares_owned_after":35276635.0,"shares_owned_after_display":"35,276,635","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-18","filed_date":"2026-08-20","scope":"insider"},{"id":9255850,"accession":"0001193125-26-354788","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-354788","line_url":"/filing/0001193125-26-354788#line-1","is_derivative":false,"issuer_cik":"0001845711","issuer_name":"Enhanced Group Inc.","issuer_ticker":"ENHA","issuer_name_source":null,"issuer_url":"/issuer/0001845711","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.; Enhanced Holdings LP","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.6521,"price_display":"1.65","price_state":"stated","total_value":330420.0,"total_display":"330,420.00","total_whole":"330,420","shares_owned_after":33062812.0,"shares_owned_after_display":"33,062,812","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-17","filed_date":"2026-08-18","scope":"insider"},{"id":9255747,"accession":"0001193125-26-353161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-353161","line_url":"/filing/0001193125-26-353161#line-1","is_derivative":false,"issuer_cik":"0001845711","issuer_name":"Enhanced Group Inc.","issuer_ticker":"ENHA","issuer_name_source":null,"issuer_url":"/issuer/0001845711","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.; Enhanced Holdings LP","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":150000.0,"shares_display":"150,000","price_per_share":1.9708,"price_display":"1.97","price_state":"stated","total_value":295620.0,"total_display":"295,620.00","total_whole":"295,620","shares_owned_after":32862812.0,"shares_owned_after_display":"32,862,812","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-14","filed_date":"2026-08-17","scope":"insider"},{"id":4133272,"accession":"0000950170-25-109858","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-109858","line_url":"/filing/0000950170-25-109858#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8675799.0,"shares_display":"8,675,799","price_per_share":2.19,"price_display":"2.19","price_state":"stated","total_value":18999999.81,"total_display":"18,999,999.81","total_whole":"19,000,000","shares_owned_after":51045214.0,"shares_owned_after_display":"51,045,214","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-08-14","filed_date":"2025-08-18","scope":"insider"},{"id":4525957,"accession":"0000950170-25-043942","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-043942","line_url":"/filing/0000950170-25-043942#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1800000.0,"shares_display":"1,800,000","price_per_share":1.4,"price_display":"1.40","price_state":"stated","total_value":2520000.0,"total_display":"2,520,000.00","total_whole":"2,520,000","shares_owned_after":42369415.0,"shares_owned_after_display":"42,369,415","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-24","scope":"insider"},{"id":4130995,"accession":"0000950170-25-023436","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-023436","line_url":"/filing/0000950170-25-023436#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10835718.0,"shares_display":"10,835,718","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":22755007.8,"total_display":"22,755,007.80","total_whole":"22,755,008","shares_owned_after":40555215.0,"shares_owned_after_display":"40,555,215","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-19","scope":"insider"},{"id":2238201,"accession":"0000950170-24-113344","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000950170-24-113344","line_url":"/filing/0000950170-24-113344#line-3","is_derivative":false,"issuer_cik":"0001194833","issuer_name":"BIONOMICS LTD/ADR","issuer_ticker":"BNOX","issuer_name_source":null,"issuer_url":"/issuer/0001194833","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.; Apeiron Presight Capital Fund II, L.P.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":557.0,"shares_display":"557","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":155.96,"total_display":"155.96","total_whole":"156","shares_owned_after":93369060.0,"shares_owned_after_display":"93,369,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-04","filed_date":"2024-10-07","scope":"insider"},{"id":2238198,"accession":"0000950170-24-113344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-113344","line_url":"/filing/0000950170-24-113344#line-2","is_derivative":false,"issuer_cik":"0001194833","issuer_name":"BIONOMICS LTD/ADR","issuer_ticker":"BNOX","issuer_name_source":null,"issuer_url":"/issuer/0001194833","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.; Apeiron Presight Capital Fund II, L.P.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":180707.0,"shares_display":"180,707","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":52405.03,"total_display":"52,405.03","total_whole":"52,405","shares_owned_after":93469320.0,"shares_owned_after_display":"93,469,320","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-03","filed_date":"2024-10-07","scope":"insider"},{"id":2238194,"accession":"0000950170-24-113344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-113344","line_url":"/filing/0000950170-24-113344#line-1","is_derivative":false,"issuer_cik":"0001194833","issuer_name":"BIONOMICS LTD/ADR","issuer_ticker":"BNOX","issuer_name_source":null,"issuer_url":"/issuer/0001194833","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.; Apeiron Presight Capital Fund II, L.P.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90806.0,"shares_display":"90,806","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":29965.98,"total_display":"29,965.98","total_whole":"29,966","shares_owned_after":125996580.0,"shares_owned_after_display":"125,996,580","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-02","filed_date":"2024-10-07","scope":"insider"},{"id":7993683,"accession":"0000921895-23-001420","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-23-001420","line_url":"/filing/0000921895-23-001420","is_derivative":false,"issuer_cik":"0001828422","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001828422","owner_cik":null,"owner_name":"Apeiron Investment Group Ltd.; Angermayer Christian; Presight Co-Invest Management, L.L.C.; Presight Sensei Co-Invest Fund, L.P.","owner_display_name":"Apeiron Investment Group Ltd.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3441661.0,"shares_display":"3,441,661","price_per_share":1.58,"price_display":"1.58","price_state":"stated","total_value":5437824.38,"total_display":"5,437,824.38","total_whole":"5,437,824","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-01","filed_date":"2023-06-02","scope":"insider","n_lines":2},{"id":8620124,"accession":"0000899243-23-009973","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-009973","line_url":"/filing/0000899243-23-009973#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Apeiron Investment Group Ltd.; Angermayer Christian","owner_display_name":"Apeiron Investment Group Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1214297.0,"shares_display":"1,214,297","price_per_share":1.318,"price_display":"1.32","price_state":"stated","total_value":1600443.446,"total_display":"1,600,443.45","total_whole":"1,600,443","shares_owned_after":32086697.0,"shares_owned_after_display":"32,086,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-03-29","filed_date":"2023-03-29","scope":"insider"},{"id":8281108,"accession":"0000921895-23-000615","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000921895-23-000615","line_url":"/filing/0000921895-23-000615","is_derivative":false,"issuer_cik":"0001828422","issuer_name":"Sensei Biotherapeutics, Inc.","issuer_ticker":"SNSE","issuer_name_source":null,"issuer_url":"/issuer/0001828422","owner_cik":null,"owner_name":"Presight Co-Invest Management, L.L.C.; Apeiron Investment Group Ltd.; Angermayer Christian; Presight Sensei Co-Invest Fund, L.P.","owner_display_name":"Presight Co-Invest Management, L.L.C.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2200.0,"shares_display":"2,200","price_per_share":1.60865,"price_display":"1.61","price_state":"stated","total_value":3539.03,"total_display":"3,539.03","total_whole":"3,539","shares_owned_after":2484823.0,"shares_owned_after_display":"2,484,823","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-23","filed_date":"2023-02-27","scope":"insider","n_lines":2},{"id":6588225,"accession":"0000899243-22-016117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-016117","line_url":"/filing/0000899243-22-016117#line-2","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21900.0,"shares_display":"21,900","price_per_share":4.4658,"price_display":"4.47","price_state":"stated","total_value":97801.02,"total_display":"97,801.02","total_whole":"97,801","shares_owned_after":1799302.0,"shares_owned_after_display":"1,799,302","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-29","filed_date":"2022-05-02","scope":"insider"},{"id":6588222,"accession":"0000899243-22-016117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-016117","line_url":"/filing/0000899243-22-016117#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34700.0,"shares_display":"34,700","price_per_share":4.4579,"price_display":"4.46","price_state":"stated","total_value":154689.13,"total_display":"154,689.13","total_whole":"154,689","shares_owned_after":1777402.0,"shares_owned_after_display":"1,777,402","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-28","filed_date":"2022-05-02","scope":"insider"},{"id":6443300,"accession":"0000899243-22-015852","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-015852","line_url":"/filing/0000899243-22-015852#line-2","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19803.0,"shares_display":"19,803","price_per_share":4.6427,"price_display":"4.64","price_state":"stated","total_value":91939.3881,"total_display":"91,939.39","total_whole":"91,939","shares_owned_after":1742702.0,"shares_owned_after_display":"1,742,702","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-27","filed_date":"2022-04-28","scope":"insider"},{"id":6443295,"accession":"0000899243-22-015852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-015852","line_url":"/filing/0000899243-22-015852#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46207.0,"shares_display":"46,207","price_per_share":4.6882,"price_display":"4.69","price_state":"stated","total_value":216627.6574,"total_display":"216,627.66","total_whole":"216,628","shares_owned_after":1722899.0,"shares_owned_after_display":"1,722,899","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-26","filed_date":"2022-04-28","scope":"insider"},{"id":6532518,"accession":"0000899243-22-015653","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-015653","line_url":"/filing/0000899243-22-015653#line-2","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Apeiron Investment Group Ltd.; Angermayer Christian","owner_display_name":"Apeiron Investment Group Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8961.0,"shares_display":"8,961","price_per_share":4.781,"price_display":"4.78","price_state":"stated","total_value":42842.541,"total_display":"42,842.54","total_whole":"42,843","shares_owned_after":1676692.0,"shares_owned_after_display":"1,676,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-25","filed_date":"2022-04-26","scope":"insider"},{"id":6532514,"accession":"0000899243-22-015653","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-015653","line_url":"/filing/0000899243-22-015653#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Apeiron Investment Group Ltd.; Angermayer Christian","owner_display_name":"Apeiron Investment Group Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52820.0,"shares_display":"52,820","price_per_share":4.827,"price_display":"4.83","price_state":"stated","total_value":254962.14,"total_display":"254,962.14","total_whole":"254,962","shares_owned_after":1667731.0,"shares_owned_after_display":"1,667,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-22","filed_date":"2022-04-26","scope":"insider"},{"id":6385962,"accession":"0000899243-22-016301","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-016301","line_url":"/filing/0000899243-22-016301#line-2","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Apeiron Investment Group Ltd.; Angermayer Christian","owner_display_name":"Apeiron Investment Group Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68688.0,"shares_display":"68,688","price_per_share":4.9505,"price_display":"4.95","price_state":"stated","total_value":340039.944,"total_display":"340,039.94","total_whole":"340,040","shares_owned_after":1614911.0,"shares_owned_after_display":"1,614,911","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-21","filed_date":"2022-05-03","scope":"insider"},{"id":6385958,"accession":"0000899243-22-016301","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-016301","line_url":"/filing/0000899243-22-016301#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Apeiron Investment Group Ltd.; Angermayer Christian","owner_display_name":"Apeiron Investment Group Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":67703.0,"shares_display":"67,703","price_per_share":5.0886,"price_display":"5.09","price_state":"stated","total_value":344513.4858,"total_display":"344,513.49","total_whole":"344,513","shares_owned_after":1546223.0,"shares_owned_after_display":"1,546,223","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-20","filed_date":"2022-05-03","scope":"insider"},{"id":6560358,"accession":"0000899243-22-015168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-015168","line_url":"/filing/0000899243-22-015168#line-2","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Apeiron Investment Group Ltd.; Angermayer Christian","owner_display_name":"Apeiron Investment Group Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65315.0,"shares_display":"65,315","price_per_share":5.125,"price_display":"5.12","price_state":"stated","total_value":334739.375,"total_display":"334,739.38","total_whole":"334,739","shares_owned_after":1478520.0,"shares_owned_after_display":"1,478,520","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-19","filed_date":"2022-04-20","scope":"insider"},{"id":6560355,"accession":"0000899243-22-015168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-015168","line_url":"/filing/0000899243-22-015168#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Apeiron Investment Group Ltd.; Angermayer Christian","owner_display_name":"Apeiron Investment Group Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":54322.0,"shares_display":"54,322","price_per_share":5.1113,"price_display":"5.11","price_state":"stated","total_value":277656.0386,"total_display":"277,656.04","total_whole":"277,656","shares_owned_after":1413205.0,"shares_owned_after_display":"1,413,205","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-18","filed_date":"2022-04-20","scope":"insider"},{"id":6620114,"accession":"0000899243-22-014963","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-014963","line_url":"/filing/0000899243-22-014963#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4967.0,"shares_display":"4,967","price_per_share":5.19,"price_display":"5.19","price_state":"stated","total_value":25778.73,"total_display":"25,778.73","total_whole":"25,779","shares_owned_after":1358883.0,"shares_owned_after_display":"1,358,883","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-14","filed_date":"2022-04-18","scope":"insider"},{"id":6385815,"accession":"0000899243-22-014797","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-014797","line_url":"/filing/0000899243-22-014797#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Angermayer Christian; Apeiron Investment Group Ltd.","owner_display_name":"Angermayer Christian","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55197.0,"shares_display":"55,197","price_per_share":4.8836,"price_display":"4.88","price_state":"stated","total_value":269560.0692,"total_display":"269,560.07","total_whole":"269,560","shares_owned_after":1353916.0,"shares_owned_after_display":"1,353,916","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-12","filed_date":"2022-04-14","scope":"insider"},{"id":6263832,"accession":"0000899243-22-014575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-014575","line_url":"/filing/0000899243-22-014575#line-2","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Apeiron Investment Group Ltd.; Angermayer Christian","owner_display_name":"Apeiron Investment Group Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":53926.0,"shares_display":"53,926","price_per_share":4.8317,"price_display":"4.83","price_state":"stated","total_value":260554.2542,"total_display":"260,554.25","total_whole":"260,554","shares_owned_after":1298719.0,"shares_owned_after_display":"1,298,719","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-12","scope":"insider"},{"id":6263828,"accession":"0000899243-22-014575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-014575","line_url":"/filing/0000899243-22-014575#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":null,"owner_name":"Apeiron Investment Group Ltd.; Angermayer Christian","owner_display_name":"Apeiron Investment Group Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":57689.0,"shares_display":"57,689","price_per_share":4.8127,"price_display":"4.81","price_state":"stated","total_value":277639.8503,"total_display":"277,639.85","total_whole":"277,640","shares_owned_after":1244793.0,"shares_owned_after_display":"1,244,793","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-04-08","filed_date":"2022-04-12","scope":"insider"},{"id":4760320,"accession":"0000899243-21-025736","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-025736","line_url":"/filing/0000899243-21-025736#line-1","is_derivative":false,"issuer_cik":"0001840904","issuer_name":"ATAI Life Sciences N.V.","issuer_ticker":"ATAI","issuer_name_source":null,"issuer_url":"/issuer/0001840904","owner_cik":"0001845872","owner_name":"Angermayer Christian","owner_display_name":"Angermayer Christian","owner_url":"/insider/0001845872","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700000.0,"shares_display":"700,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":10500000.0,"total_display":"10,500,000.00","total_whole":"10,500,000","shares_owned_after":20185200.0,"shares_owned_after_display":"20,185,200","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-22","filed_date":"2021-06-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":1,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":1},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001956439","name":"Enhanced Group Inc.","url":"/issuer/0001956439","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2026-08-17","last_seen":"2026-08-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001840904","name":"ATAI Life Sciences N.V.","url":"/issuer/0001840904","role":"Director, Ten percent owner","n_filings":13,"first_seen":"2021-06-24","last_seen":"2025-08-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001194833","name":"BIONOMICS LTD/ADR","url":"/issuer/0001194833","role":"Ten percent owner","n_filings":1,"first_seen":"2024-10-07","last_seen":"2024-10-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001829802","name":"Sensei Biotherapeutics, Inc.","url":"/issuer/0001829802","role":"Ten percent owner","n_filings":2,"first_seen":"2023-02-27","last_seen":"2023-06-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001845872","retrieved_at":"2026-08-23T19:05:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}